Clinical Trial Update: Zoledronic Acid Treatment in Patients With Congenital Dyserythropoietic Anemia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating zoledronic acid in patients with congenital dyserythropoietic anemia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Dyserythropoietic Anemia

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: Congenital Dyserythropoietic Anemia (CDA) | Phase 1, Phase 2 | Status: RECRUITING